Japanese catnip 荊芥
Pharmaceutical nameSchizonepetae Spica
The three axes are assessed independently and are never combined into a single score.
KTKP records the origin species as Schizonepeta tenuifolia (Benth.) Briq.. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same drug appears under 6 records as name variants. The same source species also yields 2 other separately registered drug(s) (Schizonepetae Folium, Schizonepetae Herba), which must not be conflated. The name most used for this taxon in current literature is Schizonepeta tenuifolia. Literature searches for this herb also cover Nepeta tenuifolia — the same taxon appears under several names.
Tradition · what the text describes
탕액편
The sub-section within this volume has not been verified against the original text yet.
The KTKP traditional materia medica record (M0004232) gives the origin species as Schizonepeta tenuifolia (Benth.) Briq., the part used as 꽃대, and the properties as 무독(無毒), 신(辛), 온(溫). It lists 간(肝), 폐(肺) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.
Properties & channel entry: 무독(無毒), 신(辛), 온(溫) · 간(肝), 폐(肺)
Source species: Schizonepeta tenuifolia (Benth.) Briq. (꽃대)
Modern · documented evidence
(no indication derived — herb-name-only search)evidence for this indication
- No indication is specified. A and B grades cannot be assigned until the query is narrowed to a specific indication.
- No indication could be derived: no condition appears on two or more registered trials for this herb.
Literature
SR 0 · RCT 1 · preclinical 43
These counts come from a herb-name-only search (0 systematic reviews, 1 RCTs). Without a specific indication they show how much the herb has been studied, not what it works for.
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Schizonepeta tenuifolia") OR (TITLE_ABS:"Nepeta tenuifolia"))- MYB Transcription Factors Negatively Regulate StL3OH in Salt Stress Response of Schizonepeta tenuifolia. (2026 · research-article; Journal Article)
- Investigating the mechanism of action of the herbal pair Schizonepeta tenuifolia Briq. and Saposhnikovia Divaricata and their active components in common allergic skin diseases. (2026 · Review; Journal Article)
- Jasmonate-responsive transcription factor StMYC2 coordinately regulates peltate glandular trichome development and monoterpenoid biosynthesis in Schizonepeta tenuifolia. (2026 · Journal Article)
- Schizonepeta tenuifolia extract improves muscle strength in aged female mice via anti-inflammatory effects. (2026 · Journal Article)
- Effect of Harvest Time on the Biofunctional Properties of Schizonepeta tenuifolia Briq. (2025 · research-article; Journal Article)
- Diosmetin, an active ingredient of Schizonepeta tenuifolia, alleviates acne by regulating inflammation and oxidative stress. (2026 · Research Support, Non-U.S. Gov't; Journal Article)
- N6-methyladenosine RNA modification regulates light intensity-dependent terpenoid biosynthesis in Schizonepeta tenuifolia. (2025 · research-article; Journal Article)
- Identification of chemical compounds of Schizonepeta tenuifolia Briq. and screening of neuraminidase inhibitors based on AUF-MS and SPR technology. (2024 · Journal Article)
- Phytochemistry and Pharmacological Activities of the Genus Schizonepeta: A Comprehensive Review Bridging Traditional Use and Modern Research. (2026 · Review; Journal Article)
- Inhibition of LPS-induced NO production by plant essential oils. (2025 · research-article; Journal Article)
Clinical trials
- NCT04510181 — UNKNOWN · NA
Safety
auto-proposed · unreviewed
- The KTKP record states the following traditional contraindication: 표허유한(表虛有汗)과 발열(發熱)이 중(重)하고 악한(惡寒)이 輕소(少)한 자(者), 혈허발열(血虛發熱), 음허화성(陰虛火盛)으로 인하여 두통목통(頭痛目痛)이 된 자(者)는 복용을 기(忌)한다.
Sources
Bridges from here
- In formulas
- 양혈거풍탕 · 거풍지보단 · 방풍통성산 · 형개연교탕
- Related patterns
- Wind-heat pattern · Liver deficiency patterns